Feb 28, 2018 21:06 pm UTC| Business
Record Revenues of $250.5 million, up 35.8% YOY Record GAAP Diluted Earnings per Share of $1.50, up 163.2% YOY Record Adjusted Earnings per Share of $1.65, up 47.3% YOY Record Policies in Force totaled approximately...
Feb 28, 2018 21:06 pm UTC| Business
Hires financial advisors to assist with divestiture of Williston and Uinta basin assets Authorizes $1.25 billion share repurchase program to be funded primarily with proceeds from asset sales DENVER, Feb. 28, 2018 --...
Monster Beverage Reports 2017 Fourth Quarter and Full Year Financial Results
Feb 28, 2018 21:06 pm UTC| Business
-- Fourth Quarter Net Sales Rise 7.5 percent to $810.4 million ---- Fourth Quarter Net Income Increases 16.4 percent to $201.3 million ---- Fourth Quarter Net Income per diluted share increases 17.5 percent to $0.35 per...
ZAGG to Report Fourth Quarter and Full Year 2017 Results on March 7, 2018
Feb 28, 2018 21:06 pm UTC| Business
SALT LAKE CITY, Feb. 28, 2018 -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile lifestyle company, will report fourth quarter and full year financial results on Wednesday, March 7, 2018, immediately following the...
FNCB Bancorp, Inc. Approved for Listing on the Nasdaq Capital Market
Feb 28, 2018 21:06 pm UTC| Business
FOR IMMEDIATE RELEASE Dunmore, PA, Feb. 28, 2018 -- FNCB Bancorp, Inc. (OTCQX: FNCB), parent company of FNCB Bank, today announced it has received approval to list its shares of common stock for trading on The...
RCM Technologies, Inc. Announces Conference Call
Feb 28, 2018 21:06 pm UTC| Business
PENNSAUKEN, N.J., Feb. 28, 2018 -- RCM Technologies, Inc. (Nasdaq:RCMT) will hold a conference call on Wednesday, March 7, 2018 at 10:00 a.m. Eastern time to discuss the financial results for the thirteen and fifty-two...
Clementia Reports 2017 Operating Results and Business Highlights
Feb 28, 2018 21:06 pm UTC| Business
Enrollment Underway in Palovarotene Phase 3 MOVE Trial for Fibrodysplasia Ossificans Progressiva (FOP) On-track to Enroll First Patient in Palovarotene Phase 2 MO-Ped Trial for Multiple Osteochondromas (MO) this Quarter ...
FxWirPro- Major Economic Events this Week